| Authors: |
Liang J; Department of Translational Medicine, Genentech, South San Francisco, CA, USA. liang.jackson@gene.com., Ong C; Department of Discovery Oncology, Genentech, South San Francisco, CA, USA., Heslop K; Department of Discovery Oncology, Genentech, South San Francisco, CA, USA., Guan J; Department of Discovery Oncology, Genentech, South San Francisco, CA, USA., Kameswaran V; Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA., Daniel B; Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA., Shi M; Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA., Liang Y; Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, CA, USA., Giltnane JM; Department of Research Pathology, Genentech, South San Francisco, CA, USA., Aimi J; Department of Translational Medicine, Genentech, South San Francisco, CA, USA., Chang CW; Department of Biostatistics, Genentech, South San Francisco, CA, USA., Gates MR; Department of Early Clinical Development, Genentech, South San Francisco, CA, USA., Eng-Wong J; Department of Early Clinical Development, Genentech, South San Francisco, CA, USA., Perez-Moreno P; Department of Product Development, Genentech, South San Francisco, CA, USA., Jhaveri KL; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA., Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, UK., Lim E; St Vincents Hospital, University of New South Wales and Garvan Institute, Sydney, NSW, Australia., Metcalfe C; Department of Discovery Oncology, Genentech, South San Francisco, CA, USA., Moore HM; Department of Translational Medicine, Genentech, South San Francisco, CA, USA. |
